Stanford scientists have taken a striking step toward reimagining type 1 diabetes treatment, using a carefully calibrated “immune reboot” to restore normal blood sugar in mice that had already ...

Nearly two million Americans are affected by type 1 diabetes. Diabetes occurs when the body cannot produce enough insulin to breakdown sugar or glucose. As a result, patients have high blood pressure ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper T cells associated with type 1 diabetes (T1D). Reported by ...

A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia. Five patients with the condition have already been dosed as part of the trial, ...

People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...

Your immune system is your body’s built-in defense network, working nonstop to protect you from bacteria, viruses, and other ...